Energenesis Biomedical (6657.TW) Earnings Analysis

Energenesis Biomedical (6657.TW) next reports earnings on 2026-08-07, consensus EPS -0.55 TWD. Last quarter (2026-05-08) it beat with EPS -0.53 TWD vs -1.18 TWD est (+55.1%). It has beaten estimates in 1/2 recent quarters (50%). Trailing P/E -15.26.

Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades

When does 6657.TW next report earnings?

Next earnings date2026-08-07
Consensus EPS estimate-0.55 TWD
Revenue estimate0.00B

6657.TW earnings history — beats and misses

Quarter (report date)EPS actualEPS est.SurpriseResult
2026-05-08-0.53 TWD-1.18 TWD+55.1%Beat
2026-02-26-0.73 TWD-0.58 TWD-25.9%Miss

Beat rate: 1/2 (50%) over reported quarters with consensus data.

6657.TW valuation and analyst view

Trailing P/E-15.26
Trailing EPS-2.36269 TWD
Price / book3.71
Dividend yield0.00%
Market cap3.15B

Limited or no published sell-side analyst coverage for this symbol.

Related research pages

Frequently asked questions

When is Energenesis Biomedical (6657.TW)'s next earnings date?

Energenesis Biomedical is next scheduled to report on 2026-08-07, with a consensus EPS estimate of -0.55 TWD and revenue estimate of 0.00B.

Did 6657.TW beat earnings last quarter?

In its 2026-05-08 report, 6657.TW posted EPS of -0.53 TWD versus a -1.18 TWD estimate — a beat of 55.1%.

What is 6657.TW's earnings track record?

Over the last 2 reported quarters with consensus data, 6657.TW beat estimates 1 times (50%).

What is 6657.TW's current P/E ratio and EPS?

6657.TW trades at a trailing P/E of -15.26 on trailing EPS of -2.362688230744734 TWD.

What do analysts rate 6657.TW?

6657.TW has limited or no published sell-side analyst coverage in our dataset, so no consensus rating is shown. Fundamentals and earnings history above are sourced from company filings via FMP.